Pharmacoinvasive Strategy vs Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Study in Mexico City

Pharmacoinvasive Strategy vs Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Study in Mexico City

Background: A low proportion of patients with ST-elevation myocardial infarction (STEMI) in low- to middle-income countries receive reperfusion therapy. Although primary percutaneous coronary intervention (PCI) is the method of choice, a pharmacoinvasive strategy (PIs) is reasonable when primary PCI...

Full description

Bibliographic Details
Main Authors: Diego Araiza-Garaygordobil, MD, MSc, Rodrigo Gopar-Nieto, MD, Alejandro Cabello-López, MD, MSc, Pablo Martinez-Amezcua, MD, MHS, Guering Eid-Lidt, MD, Luis A. Baeza-Herrera, MD, Héctor Gonzalez-Pacheco, MD, Jose Luis Briseño-De la Cruz, MD, Daniel Sierra-Lara Martinez, MD, Salvador Mendoza-García, MD, Alfredo Altamirano-Castillo, MD, Alexandra Arias-Mendoza, MD
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X20302006

Internet

http://www.sciencedirect.com/science/article/pii/S2589790X20302006

Similar Items